Country Size Color Quality

Remdesivir - Wikipedia

https://en.wikipedia.org/wiki/Remdesivir
Remdesivir (development code GS-5734) is an antiviral medication being studied during 2020 as a possible post-infection treatment for COVID-19 illness. Remdesivir is a nucleotide analog, specifically an adenosine analogue, which inserts into viral RNA chains, causing their premature termination.
Bing

Remdesivir - Cayman Chemical

https://www.caymanchem.com/product/30354/remdesivir
Remdesivir is a prodrug form of the antiviral nucleoside analog GS-441524 (Item No. 30469). 1,2 Upon entry into cells, remdesivir is metabolized into the nucleotide triphosphate GS-441524. 1 Remdesivir is active against Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome CoV (SARS-CoV) in infected primary human airway epithelial (HAE) cells (EC 50 s ...
Bing

Remdesivir | antiviral | Buy Remdesivir from Supplier AdooQ®

https://www.adooq.com/remdesivir.html
Remdesivir, also known as GS-5734, inhibits murine hepatitis virus (MHV) with an EC50 of 30 nM, and blocks SARS-CoV and MERS-CoV in HAE cells with EC50s of both 74 nM in HAE cells after treatment for 24 h.
Bing

Remdesivir Clinical Trials

https://www.gilead.com/purpose/advancing-global-health/covid-19/remdesivir-clinical-trials
Gilead has initiated two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 following the U.S. Food and Drug Administration’s (FDA) rapid review and acceptance of Gilead’s investigational new drug (IND) filing. These randomized, open ...
Bing

remdesivir – NIH Director's Blog

https://directorsblog.nih.gov/tag/remdesivir
The NIH-sponsored trial will evaluate the safety and efficacy of the experimental antiviral drug remdesivir in hospitalized adults diagnosed with COVID-19. The first participant is an American who was repatriated after being quarantined on the Diamond Princess cruise ship in Japan.
Bing

Remdesivir FDA Approval Status - Drugs.com

https://www.drugs.com/history/remdesivir.html
Remdesivir is an investigational antiviral compound undergoing clinical trials in China, the United States, and the United Kingdom as a potential treatment for COVID-19. Remdesivir is not yet licensed or approved anywhere globally and has not been demonstrated to be safe or effective for any use.
Bing

Chloroquine, hydroxychloroquine, remdesivir, Actemra? What ...

https://www.oregonlive.com/business/2020/03/chloroquine-hydroxychloroquine-remdesivir...
Remdesivir "does look like it could be promising," said Dr. Daniel Kuritzkes, chief of infectious diseases at Brigham and Women's Hospital in Boston. In animal tests, it was "quite effective at ...
Bing

Experimental coronavirus drug remdesivir Trump lauded ...

https://www.usatoday.com/story/news/2020/03/28/experimental-coronavirus-drug...
Remdesivir can only be administered by intravenous infusion over the course of between 30 and 120 minutes. It is not available as a pill or a shot. ...
Bing

Remdesivir, potential coronavirus drug, granted 'rare ...

https://www.washingtontimes.com/news/2020/mar/24/remdesivir-potential-coronavirus-drug...
Remdesivir, given through an IV, is being tested in at least five separate experiments, and Gilead also has provided it to several hundred severely ill COVID-19 patients in the U.S, Europe and ...
Bing

Coronavirus: Gilead’s Remdesivir Begins Trials as ...

https://www.genengnews.com/news/coronavirus-gileads-remdesivir-begins-trials-as...
Clinical trials of Gilead Sciences’ remdesivir have begun in Wuhan, China, the center of the novel coronavirus outbreak, a day after Chinese researchers recommended that the antiviral drug ...
Bing